Vietnam has commenced construction of its first plasma-based biopharmaceutical production plant, located in the high-tech ...

The global proteinase K market is projected to grow from US$ 27.5 million in 2023 to US$ 43.9 million by 2033, at a CAGR of 4 ...

Microbial neutralization must constantly achieve a six-log reduction threshold of Geobacillus stearothermophilus and comply ...

The global market for upstream bioprocessing equipment is on an accelerated growth trajectory, with a new market analysis by ...

Lean manufacturing – streamlining manufacturing processes to optimize productivity and reduce waste – has the potential to transform biopharmaceutical production. This webinar will explore how ...

Market growth for biopharmaceutical PAT is primarily driven by increasing biopharmaceutical production demands, stringent quality regulations, and the pursuit of process efficiency improvements.

The nanofiber microcarriers are the first of their kind for manufacturing viral vectors used in gene therapy production, according to Cellevate. Lonza signed a long-term supply agreement to ...

Combined with the 100,000-liter first plant and the 90,000-liter second plant, Celltrion’s total biopharmaceutical production capacity now stands at 250,000 liters per year. Compared to the ...

Repligen Corporation (RGEN), a life sciences company, on Monday announced the launch of its CTech SoloVPE PLUS System, an advanced ...

This innovative solution meets the specific needs of biopharmaceutical production, particularly for high-value, low-volume products such as gene and RNA therapies, monoclonal antibodies ...